# Efficacy of Inhaled Cannabis for Acute Migraine Treatment

> **NCT04360044** · PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 92 (actual)

## Conditions studied

- Migraine
- Cannabis
- THC
- CBD

## Interventions

- **DRUG:** THC ~5%
- **DRUG:** CBD ~12%
- **DRUG:** THC ~5% and CBD ~12%
- **DRUG:** Sham Cannabis

## Key facts

- **NCT ID:** NCT04360044
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-20
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04360044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04360044, "Efficacy of Inhaled Cannabis for Acute Migraine Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04360044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*